SouthState’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$17.3K Hold
82
– – ﹤0.01% 640
2026
Q2
$15.6K Sell
82
-46
-36% -$7.91K ﹤0.01% 633
2026
Q1
$21.6K Hold
128
– – ﹤0.01% 555
2025
Q4
$21.6K Hold
128
– – ﹤0.01% 567
2025
Q3
$18.5K Sell
128
-175
-58% -$23.9K ﹤0.01% 579
2025
Q2
$38.3K Hold
303
– – ﹤0.01% 542
2025
Q1
$38.8K Buy
303
+221
+270% +$30K ﹤0.01% 571
2024
Q4
$10.8K Hold
82
– – ﹤0.01% 491
2024
Q3
$11.9K Hold
82
– – ﹤0.01% 469
2024
Q2
$11.3K Hold
82
– – ﹤0.01% 481
2024
Q1
$11.3K Hold
82
– – ﹤0.01% 495
2023
Q4
$11.1K Hold
82
– – ﹤0.01% 460
2023
Q3
$10K Hold
82
– – ﹤0.01% 469
2023
Q2
$10.4K Hold
82
– – ﹤0.01% 468
2023
Q1
$10.6K Hold
82
– – ﹤0.01% 501
2022
Q4
$10.8K Sell
82
-250
-75% -$32.3K ﹤0.01% 552
2022
Q3
$39K Sell
332
-110
-25% -$13.7K ﹤0.01% 408
2022
Q2
$52K Buy
442
+62
+16% +$7.36K ﹤0.01% 397
2022
Q1
$50K Buy
380
+48
+14% +$6.25K ﹤0.01% 433
2021
Q4
$51K Hold
332
– – ﹤0.01% 396
2021
Q3
$53K Hold
332
– – ﹤0.01% 354
2021
Q2
$54K Hold
332
– – ﹤0.01% 292
2021
Q1
$50K Hold
332
– – ﹤0.01% 286
2020
Q4
$50K Hold
332
– – ﹤0.01% 280
2020
Q3
$45K Buy
332
+82
+33% +$11.1K ﹤0.01% 277
2020
Q2
$34K Sell
250
-82
-25% -$10.5K ﹤0.01% 229
2020
Q1
$36K Buy
332
+31
+10% +$3.57K 0.01% 221
2019
Q4
$36K Hold
301
– – ﹤0.01% 244
2019
Q3
$30K Sell
301
-260
-46% -$27.2K ﹤0.01% 235
2019
Q2
$61K Buy
+561
New +$59.7K 0.01% 243

Other funds holding IBB

SouthState's IBB Position: Q3 2026 in Review

SouthState held its iShares Biotechnology ETF (IBB) position steady in Q3 2026 at 82 shares worth $17.3K. The position accounts for ﹤0.01% of the portfolio, ranked #640.

SouthState first reported a position in IBB in Q2 2019 and has held it in 30 quarters since. The position peaked at $61K in Q2 2019. 920 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

  • SouthState held 82 shares of iShares Biotechnology ETF worth $17.3K as of Q3 2026.
  • SouthState left its iShares Biotechnology ETF share count unchanged in Q3 2026.
  • iShares Biotechnology ETF made up ﹤0.01% of SouthState's portfolio in Q3 2026, its #640 holding.
  • SouthState first reported a position in iShares Biotechnology ETF in Q2 2019 and has held it in 30 quarters since.
  • SouthState's iShares Biotechnology ETF position peaked at $61K in Q2 2019.
  • 920 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on SouthState's 13F filing for Q3 2026, filed 9 Nov 2026.